High-grade Serous Adenocarcinoma of the Ovary

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-12-07
Clinical Trial Update: Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi [Phase 2]
Phase 2 trial evaluating fluzoparib with or without apatinib in platinum-sensitive relapsed ovarian cancer previously treated with PARP inhi…